Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
AI drug discovery Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
SAN DIEGO, Calif., May 19, 2026 Rancho BioSciences has officially launched OmicsHQâ„¢, a comprehensive and expertly curated multi-omics data...
South San Francisco, California, March 16, 2026 Veracyte, Inc. announced the appointment of Kevin Haas, Ph.D., as Chief Development...
SAN DIEGO, CALIFORNIA | January 26, 2026 — BioTuring and 10x Genomics, a global leader in single cell and...
PALO ALTO, Calif., November 4, 2025 — Scilex Holding Company (Nasdaq: SCLX), a leading biopharmaceutical innovator specializing in non-opioid...
